Highlights

First to prove oral macromolecule delivery is clinically practical (Phase III study)
Delivers drug unaltered
Broadly applicable
- Macromolecules (e.g. proteins/peptides, carbohydrates)
- Small charged molecules
Strong existing corporate partnerships
Patent protection as of 6.30.03
- 71 U.S. patents / 53 U.S. pending
- Comparable international protection